94 related articles for article (PubMed ID: 31177609)
1. Tetramer formation by the caspase-activated fragment of the Par-4 tumor suppressor.
Clark AM; Ponniah K; Warden MS; Raitt EM; Smith BG; Pascal SM
FEBS J; 2019 Oct; 286(20):4060-4073. PubMed ID: 31177609
[TBL] [Abstract][Full Text] [Related]
2. pH-Induced Folding of the Caspase-Cleaved Par-4 Tumor Suppressor: Evidence of Structure Outside of the Coiled Coil Domain.
Clark AM; Ponniah K; Warden MS; Raitt EM; Yawn AC; Pascal SM
Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30518159
[TBL] [Abstract][Full Text] [Related]
3. Structural Analysis of the cl-Par-4 Tumor Suppressor as a Function of Ionic Environment.
Raut KK; Ponniah K; Pascal SM
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33807852
[TBL] [Abstract][Full Text] [Related]
4. Prostate apoptosis response 4 (Par-4), a novel substrate of caspase-3 during apoptosis activation.
Chaudhry P; Singh M; Parent S; Asselin E
Mol Cell Biol; 2012 Feb; 32(4):826-39. PubMed ID: 22184067
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the Conformational Stability of the cl-Par-4 Tumor Suppressor via Site-Directed Mutagenesis.
Pandey S; Raut KK; Clark AM; Baudin A; Djemri L; Libich DS; Ponniah K; Pascal SM
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189414
[TBL] [Abstract][Full Text] [Related]
6. Two-state conformational equilibrium in the Par-4 leucine zipper domain.
Schwalbe M; Dutta K; Libich DS; Venugopal H; Claridge JK; Gell DA; Mackay JP; Edwards PJ; Pascal SM
Proteins; 2010 Aug; 78(11):2433-49. PubMed ID: 20602362
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the regulatory interactions of proapoptotic Par-4.
Tiruttani Subhramanyam UK; Kubicek J; Eidhoff UB; Labahn J
Cell Death Differ; 2017 Sep; 24(9):1540-1547. PubMed ID: 28622290
[TBL] [Abstract][Full Text] [Related]
8. Caspase-8-mediated PAR-4 cleavage is required for TNFα-induced apoptosis.
Treude F; Kappes F; Fahrenkamp D; Müller-Newen G; Dajas-Bailador F; Krämer OH; Lüscher B; Hartkamp J
Oncotarget; 2014 May; 5(10):2988-98. PubMed ID: 24931006
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic disorder and coiled-coil formation in prostate apoptosis response factor 4.
Libich DS; Schwalbe M; Kate S; Venugopal H; Claridge JK; Edwards PJ; Dutta K; Pascal SM
FEBS J; 2009 Jul; 276(14):3710-28. PubMed ID: 19490121
[TBL] [Abstract][Full Text] [Related]
10. pH-induced folding of an apoptotic coiled coil.
Dutta K; Alexandrov A; Huang H; Pascal SM
Protein Sci; 2001 Dec; 10(12):2531-40. PubMed ID: 11714921
[TBL] [Abstract][Full Text] [Related]
11. Evidence of direct interaction between cisplatin and the caspase-cleaved prostate apoptosis response-4 tumor suppressor.
Raut KK; Pandey S; Kharel G; Pascal SM
Protein Sci; 2024 Mar; 33(3):e4867. PubMed ID: 38093605
[TBL] [Abstract][Full Text] [Related]
12. Caspase-3 mediated release of SAC domain containing fragment from Par-4 is necessary for the sphingosine-induced apoptosis in Jurkat cells.
Thayyullathil F; Pallichankandy S; Rahman A; Kizhakkayil J; Chathoth S; Patel M; Galadari S
J Mol Signal; 2013 Feb; 8(1):2. PubMed ID: 23442976
[TBL] [Abstract][Full Text] [Related]
13. Cloning, expression, purification, crystallization and preliminary crystallographic analysis of the C-terminal domain of Par-4 (PAWR).
Tiruttani Subhramanyam UK; Kubicek J; Eidhoff UB; Labahn J
Acta Crystallogr F Struct Biol Commun; 2014 Sep; 70(Pt 9):1224-7. PubMed ID: 25195896
[TBL] [Abstract][Full Text] [Related]
14. Systemic Par-4 inhibits non-autochthonous tumor growth.
Zhao Y; Burikhanov R; Brandon J; Qiu S; Shelton BJ; Spear B; Bondada S; Bryson S; Rangnekar VM
Cancer Biol Ther; 2011 Jul; 12(2):152-7. PubMed ID: 21613819
[TBL] [Abstract][Full Text] [Related]
15. Cancer-selective apoptosis by tumor suppressor par-4.
Hebbar N; Shrestha-Bhattarai T; Rangnekar VM
Adv Exp Med Biol; 2014; 818():155-66. PubMed ID: 25001535
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK
J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709
[TBL] [Abstract][Full Text] [Related]
17. The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU.
Kline CL; Irby RB
Apoptosis; 2011 Dec; 16(12):1285-94. PubMed ID: 21910008
[TBL] [Abstract][Full Text] [Related]
18. Protein expression and intracellular localization of prostate apoptosis response-4 (Par-4) are associated with apoptosis induction in nasopharyngeal carcinoma cell lines.
Lee JW; Lee KF; Hsu HY; Hsu LP; Shih WL; Chu YC; Hsiao WT; Liu PF
Cancer Lett; 2007 Nov; 257(2):252-62. PubMed ID: 17881119
[TBL] [Abstract][Full Text] [Related]
19. A novel isoform of prostate apoptosis response 4 (PAR-4) that co-distributes with F-actin and prevents apoptosis in neural stem cells.
Wang G; Silva J; Krishnamurthy K; Bieberich E
Apoptosis; 2006 Mar; 11(3):315-25. PubMed ID: 16520897
[TBL] [Abstract][Full Text] [Related]
20. [Pro-apoptosis and selective anticancer activities of prostate apoptosis response protein 4: research progress and prospects].
Wu Z; Wang G; Zhang K
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jan; 34(1):128-32. PubMed ID: 24463134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
